Thursday, 7 June 2018

39. Be SunSmart this Summer!


Photo: Noosa, Australia
After a long winter, the prospect of a sunshine holiday looms large in our minds. There are however risk factors in acquiring that so-called ‘healthy tan’ from sunbathing.  Over-exposure to sunlight radiation can cause three skin cancers that can kill; (malignant melanoma, squamous, or basal cell carcinoma).
To quote the Cancer Council of Australia website, “A tan is not a sign of good health or wellbeing, despite many Australians referring to a ‘healthy tan’. Almost half of Australian adults still hold the misguided belief that a tan looks healthy. Tanning is a sign that you have been exposed to enough UV radiation (from the sun or solarium) to damage your skin. This will eventually cause loss of elasticity (wrinkles), sagging, yellowish discolouration and even brown patches to appear on your skin. Worst of all, it increases your risk of skin cancer.
In the UK at least 100,000 new cases of skin cancer occur each year, and the numbers are growing. The prime cause is UV exposure from sunlight.
The sun gives off ultra-violet (UV) radiation. This radiation is an invisible killer that you can’t see or feel. Over-exposure to UV causes early aging of the skin and consequent skin damage that can lead to skin cancer. It can also cause problems with the eyes and the immune system.
Avoiding sunburns and intermittent high-intensity sun exposure (especially in children, teens, and young adults) reduces the chances of getting skin cancer. Babies and young children can easily get sunburnt, which can result in the potential for a skin cancer in later life.
The US National Cancer Institute, (NCI), recommend that people of all ages and skin tones should limit the amount of time they spend in the sun, especially between mid-morning and late afternoon, (10am – 4pm when), and avoid other sources of UV radiation, such as tanning beds.
UV radiation is reflected by sand, water, snow, ice and pavement. It can go through windshields, windows and even clouds.
Even though skin cancers are more common among people with a light skin tone, people of all skin tones can develop skin cancer, including those with dark skin.
The NCI, British Skin Foundation and the Australian Cancer Council offer tips to be sun smart and protect your skin from UV radiation.
  • Wear a hat with a wide brim all around that shades your face, neck, and ears. Baseball caps and some sun visors protect only parts of your skin.
  • Wear sunglasses that block UV radiation to protect the skin around your eyes.
  • Wear long sleeves and long pants. Tightly woven, dark fabrics are best. Some fabrics are rated with an ultraviolet protection factor (UPF). The higher the rating, the greater the protection from sunlight.
  • The British Skin Foundation and Australian Cancer Council recommend that you use a sunscreen with a sun protection factor, (SPF), of least 30. Apply the product’s recommended amount to uncovered skin preferably 30 minutes before going outside, and apply again every two hours, or after swimming or sweating.

Further Reading
British Skin Foundation

Melanoma

Basal Cell Carcinoma

Squamous Cell Carcinoma

Australian Cancer Council                                                                    
US National Cancer Institute                                                                
 Filed 01.06.2018. Caring Cancer Trust

38. Exercise as cancer treatment and prevention



Photo: University South Australia.

Exercise is an essential component of successful Cancer treatment according to the Clinical Oncology Society of Australia, (COSA) latest  Position Statement, (18 May). It highlights the crucial exercise role in Cancer Care as adjunct therapy alongside surgery, chemotherapy or radiation.

Rest and activity avoidance were historically an integral part of Cancer Care. But evidence now indisputably confirms that every person with Cancer will, (and should), benefit from the prescription of a structured exercise medicine programme.
The days when we wrapped patients in cotton wool are gone, points out Dr David Speakman of Australia’s Peter MacCallum Cancer Centre. “Our attitudes to treating cancer, what it takes to give people their best chance at survival, have to change. All cancer patients will benefit from an exercise prescription.”
COSA Associate Professor Prue Corrie comments: “Really we are at the stage where the science is telling us that withholding exercise from cancer patients can be harmful. Exercise is the best medicine someone with cancer can take in addition to standard cancer treatments. That’s because we know now that people who exercise regularly experience fewer and less severe treatment side-effects; cancer-related fatigue, mental distress, quality of life. They also have a lower risk of their cancer coming back, or dying from the disease."
Writing in the Australian research analysis publication The Coversation, Professor Cormie lays out COSA’s new thinking on exercise medicine. “If the effects of exercise could be encapsulated in a pill, it would be prescribed to every cancer patient worldwide and viewed as a major breakthrough in cancer treatment. If we had a pill called exercise it would be demanded by cancer patients, prescribed by every cancer specialist, and subsidised by government.”
Cormie recommends that health professionals worldwide should view exercise as a standard part every Cancer treatment plan, enabling patients to be as physically active as their current ability and conditions allow. For significant health benefits, they should aim for at least 150 minutes of moderate intensity aerobic exercise weekly and two to three resistance exercise sessions (such as weightlifting).
I strongly recommend readers to watch Professor Cormie’s enlightening presentation on the Youtube excerpt or listen to her 20 minute podcast published by the MJA. They are featured below.
Further Reading
COSA Position Statement
Exercise in Cancer Care
Professor Cormie, Youtube
Exercise medicine for Cancer survivors

Filed 29.05.2018 Caring Cancer Trust

37. Treating Cancer with oncolytic viruses




We tend to think of viruses as disease harbingers. Oncology researchers have found however that some viruses can be modified in the laboratory to infect and kill Cancer tumour cells while not harming healthy cells.
A small but growing number of patients are benefiting from this new-targeted but presently exceedingly expensive viral treatment approach.
After a decade of research, the US Food and Drug Administration, (FDA), and the European Medicines Agency (EMA) approved T-VEC in 2015. This is an oncolytic virus modification based on the herpes virus and approval followed successful phase III multi-centre clinical trials on patients suffering from metastasic skin cancer. It was later given the green light by the NHS in UK for use on patients with inoperable malignant melanoma. Skin cancer that is now the fifth most common cancer in UK, with more than 14,500 diagnosed each year.
Oncolytic viruses, (OVs), used in virotherapy can not only kill cancer cells, but also trigger an immune response in the body against cancer. When a virus infects a tumour cell, the virus makes copies of itself until the cell bursts. The dying cancer cell releases toxic tumour antigens. These alert the body’s immune system and stimulate it to respond to the danger, not only from nearby cancer cells in the primary cancer site but of those that have migrated to other parts of the body in a secondary malignant metastatic growth.
These are still early days in oncolytic viral research and immunotherapy. But many more studies and clinical trials are underway across the world. They will provide insights into oncolytic virus use in combination therapies that not only kill cancer cells, but also enhance the body’s immune response to promote anti-tumour immunity.
Further Reading
OncoImmunology
Human Gene Therapy

Filed 02.04.2018 Caring Cancer Trust